Rivalling Elon Musk’s Neurolink, Synchron plans brain implant trial
HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with
HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with
HQ Team April 9, 2024: Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to
HQ Team April 8, 2024: An oral spray vaccine has proved effective in halting recurrent Urinary Tract Infections (UTIs) for up to nine
HQ Team April 8, 2024: More cancer cases are being detected among the younger generation, according to a new study presented at the
HQ Team April 8, 2024: A study commissioned by the Environmental Health News and consumer watchdog site Mamavation, found that many bandage brands
HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the
HQ Team April 4, 2024: Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex’s planned acquisition of Femoston and Duphaston stating it
HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and
HQ Team April 3, 2024: Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian
HQ Team April 3, 2024: The deaths of about 100,000 cattle in India, which started two years ago, have been tracked to a